![Fred Middleton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred Middleton
Directeur/Membre du Conseil chez
Actimis Pharmaceuticals, Inc.
Fortune : 19 127 $ au 31/08/2026
Profil
Fred A. Middleton is Vice Chairman & Chief Business Officer at Altor BioScience Corp.
since 2005.
Managing Director at Sanderling Management CO LLC since 1988.
Director at Cylene Pharmaceuticals, Inc., Actimis Pharmaceuticals, Inc. since 2008, TheraVida, Inc., Lineagen, Inc. since 2008, Asteres, Inc. Member at MIT Corp.
since 2007.
Managing Director at Middleton, McNeil & Mills Associates V LLC and Mesa Verde Ventures LLC.
Formerly Chairman at Genteric, Inc. from 1978 to 2008.
Chief Financial Officer & Director at Regeneron Pharmaceuticals, Inc. from 1988 to 2001.
Director at Favrille, Inc. from 2002 to 2009.
Independent Director at CardioNet LLC in 2011.
Independent Director at Stereotaxis, Inc. from 2012 to 2018.
Director at Axikin Pharmaceuticals, Inc., CoMentis, Inc., HCW Biologics Inc. Director at Pacira Biosciences, Inc. in 2013.
Independent Director at Endocyte, Inc. from 2011 to 2018.
Director at ViaCyte, Inc. from 2020 to 2022.
Independent Director at Chimerix, Inc. from 2018 to 2025.
Independent Director at CalciMedica, Inc. from 2020 to 2026.
Chief Financial Officer & VP-Administration at Genentech, Inc. from 1978 to 1984.
Vice President-Planning & Development at The Chase Manhattan Bank NA in 1984.
Managing General Partner at Morgan Stanley & Co. LLC in 1986.
Consultant at McKinsey & Co., Inc. from 1973 to 1975.
President at Genentech Development Corp.
Education includes undergraduate degree from Massachusetts Institute of Technology in 1971 and MBA from Harvard Business School in 1973.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CALCIMEDICA, INC. 0,13% | 09/07/2026 | 8 938 ( 0,13% ) | 19 127 $ | 31/08/2026 |
Postes actifs de Fred Middleton
| Sociétés | Poste | Début |
|---|---|---|
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Private Equity Investor | 01/11/1987 |
Actimis Pharmaceuticals, Inc.
 Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Directeur/Membre du Conseil | 01/01/2008 |
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Directeur/Membre du Conseil | - |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Directeur/Membre du Conseil | - |
Middleton, McNeil & Mills Associates V LLC | Corporate Officer/Principal | - |
Lineagen, Inc.
 Lineagen, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic evaluation services | Directeur/Membre du Conseil | 01/01/2008 |
TheraVida, Inc.
 TheraVida, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products that improve the lives of patients | Directeur/Membre du Conseil | - |
Asteres, Inc.
 Asteres, Inc. Medical SpecialtiesHealth Technology Develops kiosks and lockers for the secure and safe pickup of prescriptions & healthcare products | Directeur/Membre du Conseil | - |
MIT Corp. (United States)
 MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2007 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Anciens postes connus de Fred Middleton
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Fred Middleton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
The Chase Manhattan Bank NA
 The Chase Manhattan Bank NA Major BanksFinance Provides commercial banking services | Finance |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Ventures invests in companies located in the United States. The firm participates in seed and early-stage capital transactions. It focuses on sectors such as biomedical and emerging technology. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Favrille, Inc.
 Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
CardioNet LLC
 CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Health Technology |
Stereotaxis, Inc.
 Stereotaxis, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets robotic cardiology instrument navigation systems | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Asteres, Inc.
Asteres, Inc. Medical SpecialtiesHealth Technology Develops kiosks and lockers for the secure and safe pickup of prescriptions & healthcare products | Health Technology |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Middleton, McNeil & Mills Associates V LLC | |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Health Technology |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
TheraVida, Inc.
TheraVida, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products that improve the lives of patients | Health Technology |
Lineagen, Inc.
Lineagen, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic evaluation services | Health Services |
Axikin Pharmaceuticals, Inc.
 Axikin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
CoMentis, Inc.
 CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Health Technology |
Genentech Development Corp. | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Corp. (United States)
MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Consumer Services |
HCW Biologics Inc.
 HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
